Glucose blood levels as a therapeutic target in acute ischaemic stroke setting

Veronique Guyomard, Elena I Jamieson, Phyo K Myint

Research output: Contribution to journalLiterature review

4 Citations (Scopus)

Abstract

Ischaemic stroke is extremely common in western societies contributing to 70-85% of strokes, one of the leading causes of mortality and long-term disability. Despite advancement in preventive measures, the total number of strokes is set to rise in the future due to increasing numbers of aging populations across the world. Diabetes as a risk factor for stroke has been well established. There are also emerging evidence to suggest glucose level management in acute stroke phase as a therapeutic target may be beneficial, albeit remains controversial. One of the issues in difficulty in interpreting study findings is their heterogeneity. In this article, we provide epidemiological, basic science, clinical observational and trial evidence leading to the current practice of regarding blood glucose as the therapeutic target in acute ischaemic stroke setting.

Original languageEnglish
Pages (from-to)1261-1277
Number of pages17
JournalCurrent Opinion in Chemical Biology
Volume9
Issue number14
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Medical problems
Blood Glucose
Aging of materials
Stroke
Glucose
Therapeutics
Clinical Trials
Mortality
Population

Keywords

  • Blood Glucose
  • Brain Ischemia
  • Diabetes Mellitus
  • Humans
  • Hyperglycemia
  • Stroke

Cite this

Glucose blood levels as a therapeutic target in acute ischaemic stroke setting. / Guyomard, Veronique; Jamieson, Elena I; Myint, Phyo K.

In: Current Opinion in Chemical Biology, Vol. 9, No. 14, 10.2009, p. 1261-1277.

Research output: Contribution to journalLiterature review

Guyomard, Veronique ; Jamieson, Elena I ; Myint, Phyo K. / Glucose blood levels as a therapeutic target in acute ischaemic stroke setting. In: Current Opinion in Chemical Biology. 2009 ; Vol. 9, No. 14. pp. 1261-1277.
@article{b75fe6586475430696da4e13ed9995d7,
title = "Glucose blood levels as a therapeutic target in acute ischaemic stroke setting",
abstract = "Ischaemic stroke is extremely common in western societies contributing to 70-85{\%} of strokes, one of the leading causes of mortality and long-term disability. Despite advancement in preventive measures, the total number of strokes is set to rise in the future due to increasing numbers of aging populations across the world. Diabetes as a risk factor for stroke has been well established. There are also emerging evidence to suggest glucose level management in acute stroke phase as a therapeutic target may be beneficial, albeit remains controversial. One of the issues in difficulty in interpreting study findings is their heterogeneity. In this article, we provide epidemiological, basic science, clinical observational and trial evidence leading to the current practice of regarding blood glucose as the therapeutic target in acute ischaemic stroke setting.",
keywords = "Blood Glucose, Brain Ischemia, Diabetes Mellitus, Humans, Hyperglycemia, Stroke",
author = "Veronique Guyomard and Jamieson, {Elena I} and Myint, {Phyo K}",
year = "2009",
month = "10",
doi = "10.2174/156802609789869600",
language = "English",
volume = "9",
pages = "1261--1277",
journal = "Current Opinion in Chemical Biology",
issn = "1367-5931",
publisher = "Elsevier Limited",
number = "14",

}

TY - JOUR

T1 - Glucose blood levels as a therapeutic target in acute ischaemic stroke setting

AU - Guyomard, Veronique

AU - Jamieson, Elena I

AU - Myint, Phyo K

PY - 2009/10

Y1 - 2009/10

N2 - Ischaemic stroke is extremely common in western societies contributing to 70-85% of strokes, one of the leading causes of mortality and long-term disability. Despite advancement in preventive measures, the total number of strokes is set to rise in the future due to increasing numbers of aging populations across the world. Diabetes as a risk factor for stroke has been well established. There are also emerging evidence to suggest glucose level management in acute stroke phase as a therapeutic target may be beneficial, albeit remains controversial. One of the issues in difficulty in interpreting study findings is their heterogeneity. In this article, we provide epidemiological, basic science, clinical observational and trial evidence leading to the current practice of regarding blood glucose as the therapeutic target in acute ischaemic stroke setting.

AB - Ischaemic stroke is extremely common in western societies contributing to 70-85% of strokes, one of the leading causes of mortality and long-term disability. Despite advancement in preventive measures, the total number of strokes is set to rise in the future due to increasing numbers of aging populations across the world. Diabetes as a risk factor for stroke has been well established. There are also emerging evidence to suggest glucose level management in acute stroke phase as a therapeutic target may be beneficial, albeit remains controversial. One of the issues in difficulty in interpreting study findings is their heterogeneity. In this article, we provide epidemiological, basic science, clinical observational and trial evidence leading to the current practice of regarding blood glucose as the therapeutic target in acute ischaemic stroke setting.

KW - Blood Glucose

KW - Brain Ischemia

KW - Diabetes Mellitus

KW - Humans

KW - Hyperglycemia

KW - Stroke

U2 - 10.2174/156802609789869600

DO - 10.2174/156802609789869600

M3 - Literature review

C2 - 19849664

VL - 9

SP - 1261

EP - 1277

JO - Current Opinion in Chemical Biology

JF - Current Opinion in Chemical Biology

SN - 1367-5931

IS - 14

ER -